256 Newsroom — Uganda's Digital News Infrastructure
Health

Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib - medscape.com

Published by Medscape By M. Alexander Otto, PA, MMSc · 11 August 2026 at 11:43
Share
Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib - medscape.com
Image · Medscape

What the report says

In the wake of striking survival data, more than 2000 US patients are receiving daraxonrasib before FDA approval.

Read the full report at Medscape →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

NMS Pledges to Address Medicine Shortages, Delivery Delays in WakisoNile Post 256 Newsroom Charcoal Grill serves up healthier dining - Daily MonitorDaily Monitor Development of a multiplex quantitative real-time PCR (qPCR) assay for simultaneous detection of Schistosoma haematobium and high-risk human papillomavirusesPlos.org How warnings can help persuade kids to curb their social media use - cnn.comCNN An early sign of dementia may be hiding in your voice, new research suggests - The Washington PostThe Washington Post Alcohol-linked cancer deaths have doubled in recent decades. What to know about risk. - The Washington PostThe Washington Post